Bleakley Financial Group’s Seagen Inc. Common Stock SGEN Stock Holding History

Bleakley Financial Group’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,191	Closed	-$1.53M	–	990
2023 Q3	$1.53M	Sell	7,191 -457	-6%	-$91.3K	0.05%	305
2023 Q2	$1.47M	Buy	7,648 +56	+0.7%	+$11.1K	0.05%	325
2023 Q1	$1.54M	Buy	7,592 +642	+9%	+$103K	0.05%	305
2022 Q4	$893K	Buy	+6,950	New	+$897K	0.03%	400

Other funds holding SGEN

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

FBC

Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

SAG

Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Bleakley Financial Group's SGEN Position: Q4 2023 in Review

Bleakley Financial Group sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 7,191 shares — an estimated $1.53M sold.

Bleakley Financial Group first reported a position in SGEN in Q4 2022 and held it in 4 quarters. The position peaked at $1.54M in Q1 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

Bleakley Financial Group reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Bleakley Financial Group sold 7,191 Seagen Inc. Common Stock shares in Q4 2023, an estimated $1.53M.
Bleakley Financial Group first reported a position in Seagen Inc. Common Stock in Q4 2022 and held it in 4 quarters.
Bleakley Financial Group's Seagen Inc. Common Stock position peaked at $1.54M in Q1 2023.
6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Bleakley Financial Group's 13F filing for Q4 2023, filed 25 Jan 2024.